NCT00020618View on ClinicalTrials.gov

Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2001

Study Completion Date

February 29, 2004

Conditions
PainUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

morphine sulfate

PROCEDURE

quality-of-life assessment

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT00020618 - Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain | Biotech Hunter | Biotech Hunter